Braskem SA ADR Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $12.5B-13.9% YoYTTM through 31 Dec 2024
Net Income -$1.8BTTM through 31 Dec 2024
Free Cash Flow -$214.6MTTM through 31 Dec 2024
Margins
| Current | |
|---|---|
| EBITDA Margin | -32.0% |
| Operating Margin | -1.4% |
| Net Margin | -14.6% |
Returns
264.3%ROE
-11.1%ROA
Balance Sheet Health
Current Ratio1.31x
Net Debt$8.5B
Cash & Equivalents$15B
Quality Metrics
Piotroski F-Score3 / 9
FCF Margin-1.7%
Earnings-Beat Rate66.7%
Multi-Year Trend
RevenueFY2024: $77.4B
Diluted EPSFY2020: $-8.81
Dividend
$0.67Per share, FY202240.36%Yield-2.7%5-yr growth
Capital Allocation
Capex Intensity30.0%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Brazil/South America | View detailsSupported by the expansion of the Special Regime for the Chemical Industry (REIQ) under Complementary Law No. 228, which increases PIS/Cofins tax credits on feedstock acquisition from 0.73% to 5.8%. | ||
| United States and Europe | View detailsDriven by a 6% increase in average international PP spreads and a 3% increase in sales volume. | ||
| Mexico (Braskem Idesa) | View detailsImpacted by reduced ethane supply from PEMEX and lower ethane imports aligned with Braskem Idesa's liquidity constraints. The subsidiary is currently evaluating capital structure reorganization options. |
Financials converted at 6.1779 from BRL.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.